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Abstract 
Purpose: Measurement error is an important source of bias in epidemiological studies. We 
illustrate three approaches to sensitivity analysis for the effect of measurement error: 
Imputation of the ‘true’ exposure based on specifying the sensitivity and specificity of the 
measured exposure (SS), Direct Imputation (DI) using a regression model for the predictive 
values, and adjustment based on a fully Bayesian analysis.  
Methods:  We deliberately misclassify smoking status in data from a case-control study of 
lung cancer. We then implement the SS and DI methods using fixed-parameter (FBA) and 
probabilistic (PBA) bias analyses, and Bayesian analysis using the Markov-Chain Monte-
Carlo program WinBUGS to show how well each recovers the original association.  
Results: The ‘true’ smoking-lung cancer odds ratio (OR) adjusted for sex in the original 
dataset was OR=8.18 (95% confidence limits (CL): 5.86, 11.43); after misclassification it 
decreased to OR=3.08 (nominal 95% CLs: 2.40, 3.96). The adjusted point estimates from all 
three approaches were always closer to the ‘true’ OR than the OR estimated from the 
unadjusted misclassified smoking data, and the adjusted interval estimates were always wider 
than the unadjusted interval estimate.  When imputed misclassification parameters departed 
much from the actual misclassification, the ‘true’ OR was often omitted in the FBA intervals 
whereas it was always included in the PBA and Bayesian intervals.  
Conclusions: These results illustrate how PBA and Bayesian analyses can be used to better 
account for uncertainty and bias due to measurement error. 
 
Keywords 
Misclassification · Lung cancer · Smoking status 
Sensitivity/Specificity Imputation · Direct Imputation · Fully Bayesian analysis
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 Introduction 
 
A major source of bias and uncertainty in epidemiologic analysis is measurement error, 
usually termed “misclassification” when referring to discrete variables[1-4]. Measurement 
error can be considered a missing-data problem[3] in that information has been recorded on a 
variable which is an imperfect surrogate for the missing ‘true’ variable of interest.  
 
When internal validation or replication data are not available, the true values for the 
mismeasured variables are completely missing and no consistent point estimate can be 
constructed from the data without adding further, potentially arbitrary assumptions. To 
address this problem, simple sensitivity-analysis formulae adjust for misclassification 
assuming various values for fixed misclassification rates, based on background literature or 
on external validation data[2, 13, 14]. More sophisticated analyses construct and use prior 
distributions for these rates[2-4, 13, 15-18];  in that case, standard missing-data software can 
be used by augmenting the actual data with pseudo-validation data representing these priors 
[3]. Such analyses may be repeated using different plausible priors to assess sensitivity to the 
assumed prior information. 
 
In this paper we focus on the situation where exposure has been misclassified, no validation 
data are available, and adjustment for potential confounders or matching factors is needed. 
We illustrate and compare methods to adjust for the misclassification of smoking status in a 
case-control study of smoking and lung cancer, while also adjusting for sex.  Each method 
can be carried out with commercial software. 
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Material and methods 
Methods 
In a case-control study, let Y, T and C denote the outcome (case/control status), exposure 
status (exposed/unexposed) and a dichotomous covariate. In many studies the exposure T 
cannot be directly observed and a surrogate exposure X is measured instead.  
In order to retrieve information on the ‘true’ exposure and its association with the outcome 
one has to make a priori assumptions on the relationship between T and X, i.e. on the 
misclassification rates. Assumptions can be made on one of the two following groups of 
rates: 
1. The proportion of subjects classified as exposed among those truly exposed, i.e. the 
sensitivity (Se) and the proportion of subjects classified as unexposed among those 
truly unexposed, i.e. the specificity (Sp)). This is the Sensitivity-Specificity 
imputation approach (SS). 
2. The proportion of truly exposed subjects among those classified as exposed, i.e. the 
positive predictive value (PPV), and the proportion of truly unexposed subjects 
among those classified as unexposed, i.e., the negative predictive value (NPV). This is 
the Direct Imputation approach (DI). The predictive values can be expressed as 
functions of the sensitivity, specificity, and true exposure prevalence: 
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Making assumptions about PPV and NPV is therefore equivalent to making assumptions on 
Se, Sp, and P(T=1)[A1] 
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Figure 1 summarises how information from a priori assumptions and information from the 
data are combined to provide adjusted estimates in both methods. Detailed algorithms are 
included in appendices. 
 
Figure 1 Steps of Sensitivity/Specificity Imputation Analysis (SS) and Direct Imputation 
Analysis (DI) 
Sensitivity/Specificity Imputation Analysis (SS) 
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These assumptions can be expressed with more or less uncertainty. One can define a range of 
a priori values for the misclassification proportions (fixed-parameter-bias-sensitivity analysis 
or FBA) or a priori probability distributions for these proportions (probabilistic bias analysis 
or PBA). The most rigorous way to do PBA is via Bayesian techniques[15], but a simple 
approximation is provided by Monte Carlo sensitivity analysis (MCSA) in which 
combinations of parameters are sampled from the prior distributions, and then an analysis is 
conducted for each sampled combination [2, 13, 16, 17]. Thus, MCSA involves a sensitivity 
analysis using a random sample of values for adjustments, instead of fixed values. On the 
other hand, a fully Bayesian analysis updates the prior distributions based on the study data to 
yield posterior distributions for the parameters[2, 13, 16, 17]. Procedures for MCSA have 
been implemented in Excel and SAS[2, 16].  
We consider here both SS and DI approaches, using FBA, MCSA and a fully Bayesian 
analysis. 
We use updated versions of a SAS macro implementing MCSA, which allow covariates in 
the imputation model[16] and the free software WinBUGS to implement fully Bayesian 
analysis.  
We caution that FBA and MCSA interval estimates from our analyses are not valid 
confidence intervals (they would not have 95% coverage under all fixed parameter values); 
although they may provide adequate coverage when the true parameter values are very close 
to the parameter values used in the FBA, or close to the centres of the prior distributions in 
the MCSA, but they can have poor coverage otherwise. Neither are they valid posterior 
intervals (they are not a coherent integration of prior and data information) although they can 
be adequate approximations under certain simplifying assumptions[15,17]. We therefore refer 
to them only as FBA or MCSA intervals, as appropriate, noting that the quality of the MCSA 
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approximation to Bayesian results is adequate to the extent that the distribution of sampled 
parameters would be negligibly updated by a fully Bayesian analysis. 
 
Description of the data and misclassification 
The data are from a population-based lung cancer case-control study conducted in New 
Zealand [19]. Briefly, cases were all subjects diagnosed with incident lung cancer notified to 
the New Zealand Cancer Registry during 2007 and 2008 and aged 20-75 years. Controls were 
recruited from the New Zealand Electoral Rolls of 2003 and 2008 and were frequency 
matched with the cases for age and sex. For further details see Corbin et al.[19]. 
 
We considered the association between smoking status (ever/never) and lung cancer. The 
odds ratio (OR) of lung cancer for being ever-smoker vs. never-smoker was estimated using 
unconditional logistic regression, adjusting for sex. The SAS Logistic procedure (SAS V9.3) 
was used to estimate ORs and corresponding 95% confidence intervals (95% CI). 
 
To provide a hypothetical reference point for evaluations, we assumed that our original 
dataset was correctly specified, i.e. that the ‘true’ smoking status indicator T  was known for 
all subjects. We then deliberately misclassified T  to X , and pretended that this was our 
observed measure. We attempted to use realistic misclassification rates which had been 
observed in previous studies. In 9 studies using the cotinine validation method reported by a 
meta-analysis[20], the lowest sensitivity of the self-reported smoking status was 0.82 and the 
lowest specificity was 0.91. We therefore took the original data, then misclassified T  with a 
sensitivity of 0.8 and a specificity of 0.9. The misclassification was applied nondifferentially, 
i.e. independently of the other variables (disease status, sex). In case-control studies, the 
nondifferential misclassification assumption may not hold, because cases and controls may  
 8 
 
report past behaviour differently, but the methods applied here can be extended to situations 
where misclassification is differential[2, 3, 16, 17]. 
 
Let Y, C, and X denote the indicators for case-control status, sex (1=Man, 0=Woman) and 
misclassified smoking status, respectively, and let ntycx denote the number of subjects with 
T=t, Y=y, C=c, and X=x. To create the misclassified smoking status X , we computed the 
frequencies ntyc+ in each of the 8 combinations of the categories of T, Y and C , where a 
subscript “+” indicates summation over a subscript. We then calculated the frequencies of 
classified ever/never smokers ntycx for each of these combinations as follows: 
.9.0
1.0
2.0
8.0
000
010
101
111








ycyc
ycyc
ycyc
ycyc
nn
nn
nn
nn
 
 
A preliminary analysis was conducted in order to check what possible values of sensitivity 
and specificity could have led to the misclassified odds ratio[23]. Let 
 
be the proportion 
of subjects truly ever-smokers and  the proportion of subjects classified as ever-smokers 
in the different strata of Y and C. Then   
The proportions  must fall in the range from 0 to 1, which implies the following 
restrictions: 
If se + sp > 1  
 *max YCYCSe   and  *1max YCYCSp   
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Table 1 shows the proportions of subjects classified as ever-smokers  and never-smokers 
 in strata of Y and C. Therefore, the restrictions on Se and Sp become: 
If    Se + Sp > 1 
*
11Se  (i.e. Se > 0.76) and 
*
001 Sp  (i.e. Sp > 0.59)  
If Se + Sp < 1 
*
00Se  (i.e. Se < 0.41) and 
*
111 Sp  (i.e. Sp < 0.24)  
As we assumed that self-reported smoking status was classified better than chance, we only 
considered the case where Se + Sp > 1. 
 
Table 1 Proportions of subjects classified as exposed and non-exposed in strata of Y and C 
*
YC
*
1 YC
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Results 
 
The ‘true’ odds ratio of lung cancer for ever-smokers vs. never-smokers adjusted for sex in 
the original dataset was OR=8.18 (95% CL 5.86,11.43) (log odds ratio (ln OR)=2.10, 95% 
CL 1.77, 2.44). After misclassifying the smoking status with a sensitivity of 0.8 and a 
specificity of 0.9, the estimated OR was 3.08, 95% CL 2.40, 3.96 (ln OR=1.13, 95% CL 0.87, 
1.38). 
 
Tables 2 and 3 below give the results obtained with the different methods using fixed-
parameter and probabilistic bias analyses, respectively. 
 
Table 2 Smoking-lung cancer odds ratios from SS FBA and DI FBA; 95% interval estimates 
in brackets. 
 
Table 3 Smoking-lung cancer odds ratios from SS PBA, DI PBA and Bayesian (MCMC) 
analyses 1 and 2; 95% interval estimates in brackets. 
 
When assuming sensitivity values (Se0) between 0.7 and 0.9 and specificity values (Sp0) 
between 0.8 and 1, SS FBA produced adjusted ORs ranging from 3.96 to 15.67 and DI FBA 
produced adjusted ORs between 3.88 and 17.72. However, interval estimates suggest SS FBA 
ORs would lie with 95% chance between 2.84 and 44.60 while DI FBA ORs would lie with 
95% chance between 2.97 and 26.30.[A2] 
As expected, for larger values of Se0 and Sp0, the OR obtained with SS FBA became closer to 
the OR obtained with the misclassified smoking status. The OR estimate appeared more 
sensitive to changes in the sensitivity than in the specificity of the measured exposure. When 
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Se0 was 0.7, the sensitivity was replaced by 0.77 in step (ii) of the algorithm (see Appendix 
A).  
 
Similarly, DI FBA produced adjusted ORs closer to the OR obtained with the misclassified 
smoking status when we assumed higher sensitivity and specificity. However, the adjusted 
OR was more sensitive to the value given to the OR of lung cancer in women ORTY(C=0) 
than to the values given to the sensitivity and specificity. When the values given to the 
sensitivity and the specificity were equal to the actual sensitivity and specificity of the 
introduced misclassification (Se=0.8, Sp=0.9), the OR obtained with DI FBA was very close 
to the value given to ORTY(C=0). 
 
Both the SS FBA and DI FBA interval estimates obtained after adjustment were wider on the 
logarithmic scale than the intervals obtained with the ‘standard’ analysis using misclassified 
smoking status. The intervals became narrower when increasing the sensitivity and specificity 
and when decreasing ORTY(C=0) for DI FBA. The intervals were wider when using SS FBA 
than when using DI FBA, as SS FBA also attempted to account for the uncertainty in 
estimating the prevalence of subjects classified as ever-smokers . 
 
When assuming 95% prior limits of 0.68 and 0.90 for the sensitivity and of 0.80 and 0.96 for 
the specificity and an average for ORTY(C=0) of 6.93, SS PBA ORs lied with 95% chance 
between 2.99 and 23.17, DI PBA ORs lied with 95% chance between 3.06 and 26.07, 
Bayesian analysis 1 ORs lied with 95% chance between 4.44 and 48.51 and Bayesian 
analysis 2 ORs lied with 95% chance between 4.23 and 21.78. As expected, prior means for 
the sensitivity and the specificity equal to the actual misclassification sensitivity and 
specificity gave the closest median ORs to the ‘true’ OR. 
*
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In SS PBA, out of 10,000 draws of initial sensitivity Se0, 8,799 (88%), 3,128 (31%), 4,283 
(43%) and 76 (0.76%) values for prior distributions 1, 2, 3 and 4 (see Appendix A), 
respectively, were lower or equal to 0.76 and were adjusted to 0.77. In draws of initial 
specificity Sp0 from prior distribution 3, 415 (4%) were lower or equal to 0.59 and were 
adjusted to 0.60. An increase of the prior means for the sensitivity and specificity resulted in 
a decrease of the median ORs.  When expanding the 95% limits for the sensitivity and 
specificity, the median ORs increased slightly, moving away from the ‘true’ OR and the 95% 
simulation intervals (95% SI) were much wider. For DI PBA, as for DI FBA, an increase in 
the prior means for the sensitivity and the specificity
 
still resulted in a decrease of the median 
ORs, while increasing the prior mean for ORTY(C=0) considerably increased the median 
ORs. Expanding the 95% limits for the sensitivity and the specificity slightly increased the 
median ORs and the 95% SI. Both SS and DI MCSA intervals were much wider than the 
interval estimates obtained with the original and the misclassified smoking status.  
 
As with SS PBA, median ORs obtained from fully Bayesian (MCMC) analysis 1 (defined in 
Appendix A) decreased when increasing the sensitivity and the specificity. However, median 
ORs obtained from Bayesian analysis 1 were higher than median ORs obtained with SS PBA. 
Ninety-five percent credibility intervals (95%CI) obtained from Bayesian analysis 1 were 
also wider than the 95% SI obtained with SS PBA, suggesting that SS PBA underestimates 
the uncertainty in the prevalence of true smokers in strata of T and Y. 
 
In comparison with median ORs obtained from DI PBA, median ORs obtained from 
Bayesian analysis 2 (defined in Appendix A) were more sensitive to the prior means assigned 
to the sensitivity and specificity and less sensitive to the prior mean assigned to ORTY(C=0). 
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Credibility intervals (95%CI) obtained from Bayesian analysis 2 were slightly narrower than 
DI PBA 95% SI.  
 
When the means assigned to sensitivity and specificity equalled the actual misclassification 
sensitivity and specificity, the informative prior distributions placed on Model 3 coefficients 
in Bayesian analysis 2 yielded median ORs closer to the ‘true’ OR than in Bayesian analysis 
1.  Credibility intervals were narrower after Bayesian analysis 2 than after Bayesian analysis 
1. 
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Discussion 
 
We have illustrated the use of several currently available methods for bias analysis which can 
be implemented using standard statistical software. Sensitivity/specificity (SS) imputation 
analysis has the advantage of requiring only the specification of a priori values for 
sensitivities and specificities. When one wishes to account for uncertainty about these values, 
one can specify prior distributions for the values and then sample from those[2,13,17].  
 
Nonetheless, the apparent simplicity of the SS approach has its own difficulties, since 
seemingly intuitive guesses for sensitivity and specificity may turn out to be highly 
implausible when compared to what one might deduce by considering the actual 
classification mechanism and background literature, particularly when covariates are also 
taken into account. Furthermore, prior distributions for sensitivity and specificity in PBA 
require restriction to the range of values compatible with the data (because some values may 
be impossible given the observed data) whereas fully Bayesian methods automatically 
accommodate such restrictions[15,17].  
 
Direction Imputation (DI) analysis directly models predictive values, thus eliminating the 
need for constraints on sensitivity and specificity[3]. Its main limitation is that the user needs 
to specify values or prior distributions for coefficients about which there may be poor prior 
information, including for the association of interest (here, the odds ratio of lung cancer for 
being ever smoker), and the resulting adjusted estimate can be very sensitive to that 
distribution.  
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Both SS and DI methods have been applied using fixed-parameter bias-sensitivity analysis 
(FBA) and probabilistic bias-sensitivity analysis (PBA). FBA is simpler and faster to run, 
since one only needs to specify fixed values. It is also very useful to check which values are 
compatible with the data in the SS method. Nonetheless, it does not account for uncertainty in 
the specification of the bias parameters. PBA takes this uncertainty into account and as a 
result produces wider interval estimates, thus producing inferences less sensitive to 
misspecification of the bias parameters.  
 
Rough allowance for uncertainty due to random error in PBA can be made via the addition of 
a random number to estimates during simulation. This shortcut thus leads to fast run times, 
but should be used with caution as it may seriously underestimate the actual contribution of 
random error to uncertainty about the TY association; this underestimation will be a problem 
if uncertainty due to random error is not minor compared to uncertainty about the 
classification parameters. Bootstrap or jacknife methods for adding random error are 
preferable, but can lead to long run times; bootstrapping in particular can also encounter 
technical problems in small samples[21]. 
 
The choice between SS and DI depends on what information is available. In particular, one 
needs to evaluate the amount and the quality of prior information to decide between setting 
priors on sensitivity and specificity or on regression coefficients for predictive values. When 
both validation data and prior information are available, all the information can be combined 
using data augmentation[3, 24-26], in which prior distributions are translated into new data 
records and added to the validation data. Such an approach enables analysis with standard 
methods for missing data.  
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Bayesian procedures may be preferable to PBA, especially when one feels comfortable 
assigning priors to parameters beyond the classification model[15]. Our Bayesian analyses 
indicated that the uncertainty in the prevalence of exposure might be underestimated when 
using SS PBA. In addition, unlike SS PBA, Bayesian analyses do not require truncation of 
the prior distributions when the sensitivity or specificity prior extends below the range 
compatible with the data. For further analysis and contrast of SS PBA and Bayesian analyses, 
see Maclehose and Gustafson[15]. 
 
It has been remarked that most epidemiologists write their methods and results sections as 
frequentists and their introduction and discussion sections as Bayesians[3, 27]. In their 
methods and results sections, they analyse their data as if those are the only data that exist, 
and as if there is no bias left uncontrolled by the study design or by covariate adjustment (i.e. 
they implicitly use point-null priors on hidden bias parameters[3]). In the discussion, they 
then assess their results relative to background information, examining consistency with 
previous studies, biological plausibility, and the possibility of various biases. It has been 
lamented however that in the latter discussions they severely overweight their own results, 
and tend to understate biases in these results, displaying especially poor intuitions about 
potential misclassification and measurement-error effects[2, 13, 17, 28].  
 
These problems can be mitigated by including bias analyses[2, 3, 13, 29]. FBA is particularly 
simple and may be useful for initial bias analyses, but we recommend PBA or Bayesian 
analyses when doing a risk assessment that must account for all sources of uncertainty. We 
have reviewed and illustrated several methods feasible using standard statistical software. 
Hopefully, sensitivity and bias analyses will become options in standard statistical packages 
to supplement existing methods, facilitating their conduct and presentation before inferences 
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are offered. This will enable readers to better quantitatively assess the uncertainty warranted 
in the face of methodologic problems[29].  
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KEY MESSAGES 
 We illustrate how to apply several methods for sensitivity analysis of 
misclassification, including imputation based on sensitivity and specificity, direct 
imputation based on predictive values and fully Bayesian analyses. 
 Sensitivity-Specificity Imputation requires only values or prior distributions for 
sensitivity and specificity, but these values or priors should be restricted to values 
compatible with the data. 
 Direct Imputation does not require range restrictions, but does require information 
beyond sensitivity and specificity, including a prior distribution for the association of 
interest. 
 Fully Bayesian analyses require the most prior information, but can best capture the 
uncertainty warranted under the assumed models and priors.  
 All methods should employ priors that are plausible in light of background literature. 
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